Berberry extract reduces neuronal damage and N-methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 4, 2006, Pages 623-628

  Yoo, Ki Yeon ^a   Hwang, In Koo ^a,b   Lim, Beong Ou ^c   Kang, Tae Cheon ^a   Kim, Dong Woo ^b   Kim, Sang Moo ^d   Lee, Hyeon Yong ^e   Kim, Jong Dai ^e   Won, Moo Ho ^a  

^a Hallym University   (South Korea)

^b Natural F and P Co Ltd   (South Korea)

^c Konkuk University   (South Korea)

^d Gangneung Wonju National University   (South Korea)

^e Kangwon National University   (South Korea)

Author keywords

Berberry extract; Gerbil; Hippocampal CA1 region; N methyl D aspartate receptor; Neuroprotection; Transient forebrain ischemia

Indexed keywords

BERBERIS KOREANA EXTRACT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BERBERIDACEAE; BRAIN DAMAGE; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; GERBIL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROPROTECTION; NONHUMAN; PYRAMIDAL NERVE CELL; REPERFUSION; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BERBERINE; BERBERIS; BLOTTING, WESTERN; CELL DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GERBILLINAE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; ISCHEMIC ATTACK, TRANSIENT; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXAZINES; PLANT EXTRACTS; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE STANDARDS;

EID: 33645542616     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.623     Document Type: Article

References (36)

1. Kirino T., Brain Res., 239, 57-69 (1982).
2. Petito C. K., Pulsinelli W. A., J. Cereb. Blood Flow Metab., 4, 194-205 (1984).
3. Katoh A., Ishibashi C., Shiomi T., Takahara Y., Eigyo M., Brain Res., 577, 57-63 (1992).
4. Gustafson Y., Nilsson I., Mattsson M., Astrom M., Bucht G., Drugs Aging, 7, 298-309 (1995).
5. Ivanovska N., Philipov S., Int. J. Immunopharmacol., 18, 553-561 (1996).
6. Kupeli E., Koşar M., Yeşilada E., Başer C. J. C., Başer C., Life Sci., 72, 645-657 (2002).
7. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., Fujiwara H., J. Ethnopharmacol., 66, 227-233 (1999).
8. Shamsa F., Ahmadiani A., Khosrokhavar R., J. Ethnopharmacol., 64, 161-166 (1999).
9. Marin-Neto J. A., Maciel B. C., Secches A. L., Gallo Junior L., Clin. Cardiol., 11, 253-260 (1988).
10. Ricciopo N. F., Br. J. Pharmacol., 108, 534-537 (1993).
11. Wang Y. X., Zheng Y. M., J. Cardiovasc. Pharmacol., 30, 214-222 (1997).
12. Rothman S. M., Olney J. W., Ann. Neurol., 19, 105-111 (1986).
13. Choi D. W., Rothman S. M., Annu. Rev. Neurosci., 13, 171-182 (1990).
14. Takahara A., Konda T., Enomoto A., Kondo N., Biol. Pharm. Bull., 27, 1388-1391 (2004).
15. Kang T. C., Hwang I. K., Park S. K., An S. J., Yoon D. K., Moon S. M., Lee Y. B., Sohn H. S., Cho S. S., Won M. H., J. Neurocytol., 30, 945-955 (2001).
16. Won M. H., Kang T., Park S., Jeon G., Kim Y., Seo J. H., Choi E., Chung M., Cho S. S., Neurosci. Lett., 301, 139-142 (2001).
17. Hwang I. K., Eum W. S., Yoo K. Y., Cho J. H., Kim D. W., Choi S. H., Kang T. C., Kwon O. S., Kang J. H., Choi S. Y., Won M. H., Free Radic. Biol. Med., 39, 392-402 (2005).
18. Kirino T., Tamura A., Sano K. A., Stroke, 17, 455-459 (1986).
19. Dai R., Li K., Li Q., Bi K., J. Chromatogr. Sci., 42, 207-210 (2004).
20. Xuejiang W., Ichikawa H., Konishi T., Biol. Pharm. Bull., 24, 558-563 (2001).
21. Ichikawa H., Konishi T., Biol. Pharm. Bull., 25, 898-903 (2002).
22. Yu S. J., Kim J. R., Lee C. K., Han J. E., Lee J. H., Kim H. S., Hong J. H., Kang S. G., Biol. Pharm. Bull., 28, 1016-1020 (2005).
23. Pettmann B., Henderson C. E., Neuron, 20, 633-647 (1998).
24. Nishizawa Y., Life Sci., 69, 369-381 (2001).
25. Legendre P., Rosenmund C., Westbrook G. L., J. Neurosci., 13, 674-684 (1993).
26. Okabe S., Miwa A., Okado H., J. Neurosci., 19, 7781-7792 (1999).
27. Ying Z., Babb T. L., Comair Y. G., Bingaman W., Bushey M., Touhalisky K., J. Neuropathol. Exp. Neurol., 57, 47-62 (1988).
28. McIlhinney R. A., Le Bourdelles B., Molnar E., Tricaud N., Streit P., Whiting P. J., Neuropharmacology, 37, 1355-1367 (1998).
29. Watanabe M., Fukaya M., Sakimura K., Manabe T., Mishina M., Inoue Y., Eur. J. Neurosci., 10, 478-487 (1998).
30. Huang C. G., Chu Z. L., Wei S. J., Jiang H., Jiao B. H., Thromb. Res., 106, 223-227 (2002).
31. Hui K. K., Yu J. L., Chan W. F., Tse E., Life Sci., 49, 315-324 (1991).
32. Hua Z., Wang X. L., Acta Pharm. Sin., 29, 576-580 (1994).
33. Wang F., Zhao G., Cheng L., Zhou H. Y., Fu L. Y., Yao W. X., Brain Res., 999, 91-97 (2004).
34. Yeşilada E., Kupeli E., J. Ethnopharmacol., 79, 237-249 (2002).
35. Flower R., Vane J. R., Nature (London), 240, 410-411 (1972).
36. Iadecola C., Alexander M., Curr. Opin. Neurol., 14, 89-94 (2001).